National Academy of Agricultural Sciences (NAAS)
|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Gestational Diabetes has been defined as any degree of glucose intolerance with an onset, or first recognition during pregnancy (Beckmann et al., 2005). GDM affects between 2% to 5% of pregnant women. Increasing levels of plasma glucose are associated with birth weight above the 90th percentile, and primary caesarean deliveries and neonatal hyperglycemia. Risk factors for GDM include a history of macrosomia, strong family history of diabetes, and obesity. There is a lack of uniform strategy for screening and diagnosing GDM globally. Some recommend a universal approach, whereas others exempt low – risk patients. GDM is associated with maternal and neonatal adverse outcomes. The morbidity for both the mother and the neonate can be reduced by maintaining adequate glucose levels in GDM. The cornerstone of management of GDM is glycemic control. GDM should be initially treated with diet & exercise. If these do not control the sugar levels, then insulin should be initiated. It is generally recommended that pregnancies complicated by GDM do not go beyond term.
Citations |
 |
 |
 |
 |
